Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Personalized medicine: applying 'omics' to lung fibrosis.

Biomarkers in medicine - 1 Aug 2012

Herazo-Maya Jose D, Kaminski Naftali

Abstract excerpt

Idiopathic pulmonary fibrosis (IPF), the most common fibrotic lung disease, is a chronic disease of unknown etiology with a very high mortality. Personalized medicine focuses on the use of the individual's molecular and 'omic' (i.e., genomic, epigenomic and proteomic) information to direct more efficient and cost-effective strategies for prevention, diagnosis, outcome prediction and treatment of diseases. In this...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blood Proteins
Share to Disease Susceptibility
Share to Genomics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Matrix Metalloproteinase 7

Share to Polymorphism, Single Nucleotide

Share to Precision Medicine

Share to Pulmonary Fibrosis

Share to Tumor Suppressor Proteins

Source

Open in PubMed Open full text

Identifiers

PMID: 22917154
DOI: 10.2217/bmm.12.38
PMCID: PMC3517740

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Personalized medicine: applying 'omics' to lung fibrosis.PMID 22917154Read ↗

Genetics of idiopathic pulmonary fibrosis: from mechanistic pathways to personalised medicine.Semantic proximity Read ↗

PROFILEing idiopathic pulmonary fibrosis: rethinking biomarker discovery.Semantic proximity Read ↗

Integrative omics analysis identifies biomarkers of idiopathic pulmonary fibrosisSemantic proximity Read ↗

Fibrosis: Lessons from OMICS analyses of the human lungSemantic proximity Read ↗

Exploring the Cellular and Molecular Landscape of Idiopathic Pulmonary Fibrosis: Integrative Multi-Omics and Single-Cell AnalysisSemantic proximity Read ↗

Personalized Medicine and Proteomics: Lessons from Non-Small Cell Lung CancerSemantic proximity Read ↗

Using omics approaches to understand pulmonary diseasesSemantic proximity Read ↗

Personalized Medicine: What's in it for Rare Diseases?Semantic proximity Read ↗

Idiopathic pulmonary fibrosis and the role of genetics in the era of precision medicineSemantic proximity Read ↗

Personalised medicine in interstitial lung diseases: Number 6 in the Series "Personalised medicine in respiratory diseases" Edited by Renaud Louis and Nicolas Roche.Semantic proximity Read ↗

Genetics in Idiopathic Pulmonary Fibrosis Pathogenesis, Prognosis, and TreatmentSemantic proximity Read ↗

Evolving Genomic Approaches to Idiopathic Pulmonary Fibrosis: Moving Beyond GenesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.